transplant

Fierce Pharma

FDA delays decision on Orca Bio’s cell therapy for blood cancers

The delay comes at a time when the biopharma industry is highly attuned to FDA actions on cell and gene therapies after a string of regulatory surprises.

Angus Liu Apr 1, 2026 8:00am

Precise Bio completes 1st 3D-printed human cornea transplant

Nov 19, 2025 8:30am

Graphic of sound waves entering a persons ear

Lineage tunes up hearing loss transplant with $12M research pact

Aug 26, 2025 11:00am

Lower part of a runner with prosthetic leg running along a park

Fibroblast cell therapy toughens skin in small clinical trial

Sep 9, 2024 2:26pm

Pulmocide exits OPERA with evidence of antifungal efficacy

Apr 15, 2024 9:41am

NIH study illustrates race disparities in heart failure therapy

Oct 20, 2022 10:46am